MTC
GILD icon

Matrix Trust Company’s Gilead Sciences GILD Stock Holding History

Matrix Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
159
+38
+31% +$5.01K ﹤0.01% 94
2026
Q1 		$17K Buy
+121
New +$16.9K ﹤0.01% 138
2025
Q4 		– Sell
-1,299
Closed -$144K – 247
2025
Q3 		$144K Buy
1,299
+4
+0.3% +$455 0.02% 145
2025
Q2 		$144K Buy
1,295
+107
+9% +$11.4K 0.02% 152
2025
Q1 		$133K Buy
1,188
+136
+13% +$14K 0.02% 160
2024
Q4 		$97K Buy
1,052
+881
+515% +$79.3K 0.02% 135
2024
Q3 		$14K Buy
+171
New +$13K ﹤0.01% 199

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Matrix Trust Company's GILD Position: Q2 2026 in Review

Matrix Trust Company increased its Gilead Sciences (GILD) stake by 31% in Q2 2026, buying an estimated $5.01K and bringing the position to 159 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #94.

Matrix Trust Company first reported a position in GILD in Q3 2024 and has held it in 7 quarters since. The position peaked at $144K in Q3 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Matrix Trust Company held 159 shares of Gilead Sciences worth $20K as of Q2 2026.
  • Matrix Trust Company bought 38 Gilead Sciences shares in Q2 2026, an estimated $5.01K.
  • Gilead Sciences made up ﹤0.01% of Matrix Trust Company's portfolio in Q2 2026, its #94 holding.
  • Matrix Trust Company first reported a position in Gilead Sciences in Q3 2024 and has held it in 7 quarters since.
  • Matrix Trust Company's Gilead Sciences position peaked at $144K in Q3 2025.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.